Position in BCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$954,270
+$787,090 QoQ
Shares Held
95,427
+443.4% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#125
of 316 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026EntryPoint Capital, LLC holds $3,628,447 across 7 Drug Manufacturers - Specialty & Generic names. BCRX ranks #1 (26.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
95,427 | $954,270 | |
| 2 | ZTS |
Zoetis Inc.
|
10,184 | $731,822 | |
| 3 | HLN |
Haleon plc
|
69,665 | $649,974 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
80,750 | $639,540 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
4,181 | $346,103 | |
| 6 | SIGA |
Siga Technologies Inc
|
60,349 | $219,670 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
10,390 | $87,068 |
All Filings in BCRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $954,270 | 95,427 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $167,180 | 17,561 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $98,989 | 12,691 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $321,163 | 42,314 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $349,664 | 39,025 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $303,960 | 40,528 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $408,598 | 53,763 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $363,538 | 58,825 | Shares | Sole | 2026-08-13 | |
| 2024-03-31 | $216,809 | 42,679 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $32,369 | 5,404 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||